Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	48.25	77.85	52.51
Graham Fair Price	-3.02	2.60	2.68
PEG	297.31	0.60	0.15
Price/Book	-38.02	207.06	334.08
Price/Cash Flow	-15.37	148.37	175.31
Prices/Earnings	94.05	-92.36	47.60
Price/Sales	16.74	10.39	8.90
Price/FCF	-15.37	148.37	175.31
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-2.97	0.42	0.44
Operating Margin	-49.86	0.13	0.26
ROA	-44.19	< 0.005	0.02
ROE	1.75	-0.56	-68.06
ROIC	0.11	0.09	-21.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.03	-0.02	-50.78
Dividends QOQ	< 0.005	< 0.005	-346.24
EBIT QOQ	1.26	-0.54	-56.75
EPS QOQ	3.17	-1.55	-51.16
FCF QOQ	26.25	0.26	-99.02
Revenue QOQ	0.44	-0.09	-79.71
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	52.45	57.88	10.36
Days Sales Outstanding (DSO)	30.71	33.39	8.73
Inventory Turnover	1.72	1.55	-9.39
Debt/Capitalization	0.98	0.97	-1.28
Quick Ratio	0.51	0.48	-5.51
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	0.43	0.73	71.60
Cash	2.86	1.76	-38.35
Capex	-0.42	-0.44	-5.71
Free Cash Flow	0.81	1.02	25.67
Revenue	16.03	14.60	-8.90
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.89	0.90	0.85
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.11	10.08	41.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating